TRASTUZUMAB EMTANSINE, Herceptin 150 mg powder for concentrate for solution for infusion, 89Zr-Trastuzumab_IJB
IJB-ZEPHIR02-2024
Phase 2 small_molecule active
Quick answer
TRASTUZUMAB EMTANSINE, Herceptin 150 mg powder for concentrate for solution for infusion, 89Zr-Trastuzumab_IJB for advanced/metastatic HER2-positive breast carcinoma is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- advanced/metastatic HER2-positive breast carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active